Ireland
--:--IST
Latest
Clinical Trials in Norway / NCT06079255
Starting soon Observational

Ischemia Detection During Development of Acute Compartment Syndrome

NCT06079255 · tracked via the Priya Life Science Norway tracker
Phase
Observational
Started
2025-10-15
Last updated
2025-03-25

Condition(s) studied

Ischemia LimbBlood Circulation DisorderCarbon DioxideBiosensing TechniquesCompartment Syndrome of Leg

Investigational drug(s) / intervention(s)

IscAlert sensor(s) in patient with risk of acute compartment syndrome

IscAlert sensor(s) in patient with risk of acute compartment syndrome: of the replanted extremity Insertion of a CO2- and temperature sensor(s) (IscAlert) in the anterior compartment of a lower limb (leg)

Study summary

This is an open, observational, prospective, descriptive, single-centre study including 60 patients. The study is designed to investigate if IscAlert sensor system can be used for reliable and continuous tissue carbon dioxide (pCO2)- and temperature monitoring in muscular tissue in lower extremity in patients at risk of developing acute compartment syndrome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
110 Years
Healthy volunteers
No
Inclusion Criteria: * Must have a leg fracture that, perceived by the clinician, could give rise to later developing acute compartment syndrome condition. * Subject must be 18 years or more. * Able to sign informed consent. * Expected cooperation of the patients for the treatment and follow up Exclusion Criteria: * Another study interfering with current study * Any reason why, in the opinion of the investigator, the patient should not participate. * Patients where a fasciotomy has already been decided should be performed

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Oslo University Hospital Oslo Norway

More Oslo University Hospital trials in Norway

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06079255 on ClinicalTrials.gov ↗ ← All trials in Norway